Publication | Open Access

Immunosuppressive TREM2(+) macrophages are associated with undesirable prognosis and responses to anti-PD-1 immunotherapy in non-small cell lung cancer

Anti-pd-1 ImmunotherapyCancer ImmunosurveillanceMedicineImmunologyUndesirable PrognosisBronchial NeoplasmImmune Checkpoint InhibitorImmunosuppressionImmunotherapyOncologyRadiation OncologyLung CancerImmunosuppressive Trem2